Ursprung des Netzwerks ersten Grades von Mike Ford
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Leadiant Biosciences SpA
 Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mike Ford
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Pharmaceuticals: Major | President Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Leadiant Biosciences Ltd.
 Leadiant Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences Ltd. researches, manufactures, and markets therapies for patients. The private company is based in London, UK, and has subsidiaries in Germany. The British company was founded in 1957. Antonio Gama da Silva has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Milan | College/University | Doctorate Degree Doctorate Degree | |
| LEE'S PHARMACEUTICAL HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Exelead, Inc.
 Exelead, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Exelead, Inc. is a biopharmaceutical contract development and manufacturing company. The company is based in Indianapolis, IN. John Rigg has been the CEO of the company since 2014. Exelead was acquired by Merck KGaA from Leadiant Biosciences SA on February 23, 2022 for $780 million. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GENTIUM S.P.A. (ADR) | Pharmaceuticals: Major | Director/Board Member | |
| Rostaquo | Director/Board Member | ||
| Thule Therapeutics SA | Director/Board Member | ||
Leadiant Biosciences SA
 Leadiant Biosciences SA Miscellaneous Commercial ServicesCommercial Services Leadiant Biosciences SA conducts biotechnological research. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Wake Forest School of Medicine | College/University | Doctorate Degree | |
| REGENERX BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Leeds | College/University | Undergraduate Degree | |
Naicons Srl
 Naicons Srl Packaged SoftwareTechnology Services Naicons Srl develops a game-changing drug discovery platform. The private company is based in Milan, Italy. | Packaged Software | Director/Board Member | |
Nerviano Medical Sciences SRL
 Nerviano Medical Sciences SRL Pharmaceuticals: MajorHealth Technology Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Accelera Srl
 Accelera Srl BiotechnologyHealth Technology Accelera SRL operates as an drug discovery development research organization. It offers discovery, development, and bioanalysis and PK services. The company is headquartered in Nerviano, Italy. | Biotechnology | Corporate Officer/Principal | |
Essetifin SpA
 Essetifin SpA Pharmaceuticals: MajorHealth Technology Essetifin SpA operates as a holding company. The company was founded in 1957 and is headquartered in Rome, Italy. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| FENNEC PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Sigma Tau Rare Diseases SA | Chief Executive Officer | ||
Servier IP UK Ltd.
 Servier IP UK Ltd. Medical DistributorsDistribution Services Part of Baxter International, Inc., Servier IP UK Ltd. is a company that wholesales pharmaceutical products. Servier IP UK Ltd. is based in Slough, UK. Servier IP was acquired by Baxter International, Inc. from Essetifin SpA on July 23, 2015 for $1,255.92 million. | Medical Distributors | Chief Executive Officer | |
| SOLIGENIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Tecnogen SpA
 Tecnogen SpA Electrical ProductsProducer Manufacturing Tecnogen SpA provides electric generators. It also offers lighting towers. The firm has a capacity of 35000 units for the global market and has branch offices in the United Kingdom, Germany, and Singapore. The company is headquartered in Piacenza, Italy. | Electrical Products | Chief Executive Officer | |
| Prassis - Istituto di Ricerche Sigma-Tau SpA | Chief Executive Officer | ||
| Sigma-Tau Research Switzerland SA | President | ||
| Metheresis Translational Research SA | Director/Board Member |
Statistik
International
| Italien | 10 |
| Vereinigte Staaten | 7 |
| Schweiz | 6 |
| Vereinigtes Königreich | 4 |
| Hong Kong | 2 |
Sektoral
| Health Technology | 13 |
| Consumer Services | 4 |
| Commercial Services | 2 |
| Technology Services | 2 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 19 |
| Chief Executive Officer | 7 |
| Corporate Officer/Principal | 6 |
| Independent Dir/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Marco Brughera | 19 |
| Alessandro Noseda | 9 |
| Simon Miles Ball | 6 |
| Andrea Dini | 1 |
| Raffaele Sanguigni | 1 |
